This inventor holds 4 USPTO granted patents. Top assignees: Smithkline Beecham Corporation, Other. Active years: 1999-2001.
Company Filing History:
3 out of 2,198 
1 out of 834,350 Years Active: 1999-2001
Title: William Henry Holms: Innovator in Clavam Antibiotic Production
Introduction
William Henry Holms, an accomplished inventor based in Glasgow, GB, has made significant contributions to the field of microbiology and antibiotic production. With a total of four patents to his name, Holms has focused on improving the processes involved in the fermentative preparation of clavam derivatives, enhancing both efficiency and yield in antibiotic production.
Latest Patents
Holms's latest patents showcase his innovative approach to biotechnological processes. One of his notable patents is a “Process for the fermentative preparation of clavam derivatives,” which emphasizes keeping ammonia and urea levels low in the fermentation medium. This method is designed to prevent enzyme repression, specifically urease, thus improving the fermentation process. Another significant patent is titled “Process to increase the production of clavam antibiotics.” This innovation details a method to increase clavam production by interfering with the conversion of L-lysine to L-α-aminoadipic acid in the cephalosporin pathway, utilizing plasmids with defective lysine amino transferase genes to enhance yield.
Career Highlights
William Henry Holms has had a notable career, with experiences at key companies such as SmithKline Beecham Corporation, where he contributed his expertise to the development of antibiotic technologies. His work has played an essential role in advancing methods that underpin modern antibiotic production.
Collaborations
Throughout his career, Holms has collaborated with several prominent figures in the field, including David Michael Mousdale and Brian Peter Valentine. These partnerships have fostered knowledge exchange and innovation, contributing to successful advancements in microbiological research.
Conclusion
William Henry Holms exemplifies the spirit of innovation in the area of antibiotic production. His patents and collaborative efforts have significantly impacted the development of clavam derivatives, making him a notable figure in the realm of microbiological research and innovation. His ongoing work continues to pave the way for improvements in antibiotic strategies, showcasing the essential role of inventors in medical progress.